Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor

被引：3
|
作者：
Wiwanitkit, Somsri
Wiwanitkit, Viroj [1 ,2 ]
机构：
[1] Univ Nis, Fac Med, Nish, Serbia
[2] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2013年 / 59卷 / 03期
关键词：
D O I：
10.1016/j.ramb.2012.12.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [21] Aromatase inhibitors: Role in postmenopausal breast cancer
    Kharb, Rajeev
    Haider, Kashif
    Neha, Kumari
    Yar, Mohammad S.
    ARCHIV DER PHARMAZIE, 2020, 353 (08)
  • [22] Aromatase inhibitors for breast cancer in postmenopausal women
    Campos, SM
    ONCOLOGIST, 2004, 9 (02): : 126 - 136
  • [23] Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer
    Younis, T.
    Rayson, D.
    Dewar, R.
    Skedgel, C.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 293 - 298
  • [24] Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer
    Dowsett, M
    Pfister, C
    Johnston, SRD
    Miles, DW
    Houston, SJ
    Verbeek, JA
    Gundacker, H
    Sioufi, A
    Smith, IE
    CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2338 - 2343
  • [25] In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients
    Geisler, J
    King, N
    Anker, G
    Ornati, G
    Di Salle, E
    Lonning, PE
    Dowsett, M
    CLINICAL CANCER RESEARCH, 1998, 4 (09) : 2089 - 2093
  • [26] Changes in lipid-levels following aromatase inhibitor treatment in early postmenopausal breast cancer
    Lund, M.
    Corn, G.
    Jensen, M-B.
    Petersen, T. S.
    Dalhoff, K.
    Ejlertsen, B.
    Kober, L.
    Wohlfahrt, J.
    Melbye, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S341 - S341
  • [27] Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model
    Jelovac, D
    Macedo, L
    Goloubeva, OG
    Handratta, V
    Brodie, AMH
    CANCER RESEARCH, 2005, 65 (12) : 5439 - 5444
  • [28] Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
    Philipovskiy, Alexander
    Campbell, Aleli
    Heydarian, Rosalinda
    Castillo, Brenda
    Dwivedi, Alok K.
    Mccallum, Richard
    Aguilera, Renato
    Gaur, Sumit
    Nahleh, Zeina
    ANTICANCER RESEARCH, 2020, 40 (02) : 857 - 864
  • [29] A nationwide data on the cardiovascular protective effect of tamoxifen and aromatase inhibitor in postmenopausal women with breast cancer
    Moon, H-G
    Choi, S. H.
    Park, Y.
    Jung, J. G.
    Ju, Y. W.
    Kim, K. E.
    Kim, Y.
    Lee, E.
    Lee, H-B
    Han, W.
    Noh, D-Y
    Yoon, H-J
    CANCER RESEARCH, 2019, 79 (04)
  • [30] A STUDY OF FADROZOLE, A NEW AROMATASE INHIBITOR, IN POSTMENOPAUSAL WOMEN WITH ADVANCED METASTATIC BREAST-CANCER
    RAATS, JI
    FALKSON, G
    FALKSON, HC
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) : 111 - 116
12345